These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14074844)

  • 21. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I
    Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Donor leukocyte transfusion in a patient with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation: analysis of natural killer cell activity and T-cell receptor repertoire in bone marrow T cells that exhibited graft-versus-leukemia activity].
    Suehiro Y; Muta K; Umemura T; Motomura S; Nishimura J; Nawata H; Kimura N
    Rinsho Ketsueki; 1999 Jan; 40(1):40-5. PubMed ID: 10067095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful engraftment of blood derived normal hemopoietic stem cells in chronic myelogenous leukemia.
    Körbling M; Burke P; Braine H; Elfenbein G; Santos G; Kaizer H
    Exp Hematol; 1981 Jul; 9(6):684-90. PubMed ID: 6114872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Unrelated donor allogenetic marrow transplantation in treatment of acute and chronic leukemia].
    Huang H; Lin M; Meng H
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):263-7. PubMed ID: 11798883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of re-appearance of BCR-ABL-positive cells years after allogeneic bone marrow transplantation for chronic-phase chronic myelogenous leukemia in patients in hematological remission.
    Diekmann L; Beelen DW; Quabeck K; Becher R; Schulte Holthausen H; Bützler R; Schaefer UW; Opalka B
    Acta Haematol; 1994; 92(4):169-75. PubMed ID: 7701913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program.
    Muramatsu H; Kojima S; Yoshimi A; Atsuta Y; Kato K; Nagatoshi Y; Inoue M; Koike K; Kawase T; Ito M; Kurosawa H; Tanizawa A; Tono C; Hamamoto K; Hotta N; Watanabe A; Morishima Y; Kawa K; Shimada H
    Biol Blood Marrow Transplant; 2010 Feb; 16(2):231-8. PubMed ID: 19800016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.
    Porter DL; Roth MS; McGarigle C; Ferrara JL; Antin JH
    N Engl J Med; 1994 Jan; 330(2):100-6. PubMed ID: 8259165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antileukemic effects of rapid cyclosporin withdrawal in patients with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation.
    Brandenburg U; Gottlieb D; Bradstock K
    Leuk Lymphoma; 1998 Nov; 31(5-6):545-50. PubMed ID: 9922044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MITOTIC ABILITY OF LEUKEMIC LEUKOCYTES IN CHRONIC MYELOCYTIC LEUKEMIA.
    SANDBERG AA; KIKUCHI Y; CROSSWHITE LH
    Cancer Res; 1964 Sep; 24():1468-73. PubMed ID: 14221804
    [No Abstract]   [Full Text] [Related]  

  • 30. LEUKOKINETIC STUDIES. X. BLOOD GRANULOCYTE KINETICS IN CHRONIC MYELOCYTIC LEUKEMIA.
    ATHENS JW; RAAB SO; HAAB OP; BOGGS DR; ASHENBRUCKER H; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1965 May; 44(5):765-77. PubMed ID: 14276134
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term remission of T-lymphoid extramedullary blast crisis of chronic myelogenous leukemia following allogeneic bone marrow transplantation.
    Montefusco E; Mauro FR; Lo Coco F; Rondinelli B; Arcese W; Tabilio A; Monarca B; Alimena G; Mandelli F
    Haematologica; 1990; 75(4):391-3. PubMed ID: 2276682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation by bcr-abl mRNA and DNA fingerprinting.
    Okamoto R; Harano H; Matsuzaki M; Motomura S; Maruta A; Kodama F; Mohri H; Okubo T
    Am J Clin Pathol; 1995 Nov; 104(5):510-6. PubMed ID: 7572810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of childhood acute lymphocytic leukemia.
    Pinkel D
    J Pediatr; 1970 Dec; 77(6):1089-91. PubMed ID: 4922336
    [No Abstract]   [Full Text] [Related]  

  • 35. Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. The EBMT Paediatric Diseases Working Party.
    Dini G; Rondelli R; Miano M; Vossen J; Gluckman E; Peters C; Bordigoni P; Locatelli F; Miniero R; Ljungman P; Saarinen U; Klingebiel T; Ortega J; Lanino E
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():80-5. PubMed ID: 8932805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent antileukemic activity of the novel agents norsegoline and dibezine.
    Einat M; Nagler A; Lishner M; Amiel A; Yarkoni S; Rudi A; Gellerman G; Kashman Y; Fabian I
    Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HEMATOPOIETIC GRAFT DETECTED BY A CHANGE IN ABO GROUP.
    BRONSON WR; MCGINNISS MH; MORSE EE
    Blood; 1964 Feb; 23():239-49. PubMed ID: 14122248
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Drobyski WR; Roth MS; Thibodeau SN; Gottschall JL
    Bone Marrow Transplant; 1992 Sep; 10(3):301-4. PubMed ID: 1422483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program.
    Miyamoto T; Fukuda T; Nakashima M; Henzan T; Kusakabe S; Kobayashi N; Sugita J; Mori T; Kurokawa M; Mori SI
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):938-944. PubMed ID: 28219836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allogeneic bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in childhood.
    Lin YT; Lin DT; Jou ST; Lin KS; Lin KH
    J Formos Med Assoc; 1997 May; 96(5):320-4. PubMed ID: 9170818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.